RxDoctor Payments DataLook up a doctor →

Jon Durrani, DO

Neurology · Centerville, OHNPI 1932495157

Payments from drug & device makers

$412,536in general payments, 2019–2025

Across 1,504 payments — averaging $274.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$146K
  • UCB, Inc.$123K
  • Argenx US, Inc.$85K
  • AbbVie$30K
  • Johnson & Johnson$12K
  • Amgen$3K
  • plus $14K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)173$145,919
UCB, Inc.214$123,465
Argenx US, Inc.99$85,389
AbbVie(2 entities)230$29,523
Johnson & Johnson(2 entities)20$11,882
Amgen(2 entities)38$2,758
Jazz Pharmaceuticals Inc.16$2,739
Supernus Pharmaceuticals, Inc.86$1,098
Biogen46$872
Novartis69$865
Teva Pharmaceuticals USA, Inc.53$861
SK Life Science, Inc.42$686
Lilly USA, LLC56$587
Eisai Inc.31$478
Tempus AI, Inc14$413
Amneal Pharmaceuticals LLC21$379
Neurocrine Biosciences, Inc.16$337
Pfizer20$310
Zyla Life Sciences, Inc.38$287
Genentech USA, Inc.15$265
MDD US Operations, LLC12$228
Biohaven Pharmaceuticals, Inc.22$225
Lundbeck LLC11$210
Sanofi11$195
Sunovion Pharmaceuticals Inc.14$182
Catalyst Pharmaceuticals, Inc.8$173
Harmony Biosciences LLC9$172
Acadia Pharmaceuticals Inc9$165
Biohaven Pharmaceutical Holding Company Ltd.12$149
Avanir Pharmaceuticals, Inc.8$137
Acorda Therapeutics, Inc9$131
Greenwich Biosciences, Inc.12$118
Neurelis, Inc.6$111
CSL Behring4$99
Orthofix Medical, Inc.1$88
Axsome Therapeutics, Inc.5$84
EMD Serono, Inc.4$83
Sumitomo Pharma America, Inc.4$82
Takeda Pharmaceuticals U.S.A., Inc.4$76
Sandoz3$74
Ipsen Biopharmaceuticals, Inc4$59
Adamas Pharmaceuticals, Inc.4$53
Merz North America, Inc.2$48
E.r. Squibb & Sons, L.L.C.3$47
Alnylam Pharmaceuticals Inc.2$44
Merz Pharmaceuticals, LLC2$42
Grifols USA, LLC2$42
TG Therapeutics, Inc.2$38
Aprecia Pharmaceuticals, LLC2$36
Vertical Pharmaceuticals, LLC3$35
Amylyx Pharmaceuticals, Inc.2$32
Tanabe Pharma America, Inc.2$32
Octapharma USA, Inc.2$30
Bristol Myers Squibb1$20
Assertio Therapeutics, Inc.1$19
Corium, LLC1$18
Aucta Pharmaceuticals, Inc.2$18
Currax Pharmaceuticals LLC1$18
Alfasigma USA, Inc.1$13

How this compares

$412,536 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$283,408
Medicare patients
445
Services billed
9,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Centerville

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →